memoxa 10 mg/1 tableta tableta
amsal pharmaceuticals d.o.o. - Винпоцетин - tableta - 10 mg/1 tableta - jedna tableta sadrži: 10 mg vinpocetin
memoxa 5 mg/1 tableta tableta
amsal pharmaceuticals d.o.o. - Винпоцетин - tableta - 5 mg/1 tableta - jedna tableta sadrži: 5 mg vinpocetina
memoxa 10 mg/1 tableta tableta
amsal pharmaceuticals d.o.o. - Винпоцетин - tableta - 10 mg/1 tableta - jedna tableta sadrži: 10 mg vinpocetina
ledaga
helsinn birex pharmaceuticals ltd. - chlormethine - mycosis fungoides - antineoplastična sredstva - ledaga je indicirana za topičko liječenje limfoma t-stanica (tipa mf-tipa ctcl) tipa mikoza fungoida u bolesnika odraslih.
voxzogo
biomarin international limited - vosoritide - achondroplasia - lijekovi za liječenje bolesti kostiju - voxzogo is indicated for the treatment of achondroplasia in patients 4 months of age and older whose epiphyses are not closed. the diagnosis of achondroplasia should be confirmed by appropriate genetic testing.
zavicefta
pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - antibakterijski lijekovi za sistemsku primjenu, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. treba uzeti u obzir formalne preporuke za odgovarajuće korištenje antibakterijskih posrednika.
luxturna
novartis europharm limited - voretigene neparvovec - leber congenital amaurosis; retinitis pigmentosa - other ophthalmologicals - luxturna je indiciran za liječenje i odjelu odraslih bolesnika s gubitkom vida zbog ostavština distrofije mrežnice uzrokovana potvrdio rpe65 биаллельных mutacija i koji imaju dovoljno živih stanica mrežnice.
hyperil plus 10 mg/1 tableta+ 12.5 mg/1 tableta tableta
zada pharmaceuticals d.o.o. - hidrohlorotiazid, lizinopril - tableta - 10 mg/1 tableta+ 12.5 mg/1 tableta - 1 tableta sadrži: 10 mg lizinopril (u obliku lizinopril, dihidrata) i 12,5 mg hidrohlorotiazid
hyperil plus 20 mg/1 tableta+ 12.5 mg/1 tableta tableta
zada pharmaceuticals d.o.o. - hidrohlorotiazid, lizinopril - tableta - 20 mg/1 tableta+ 12.5 mg/1 tableta - 1 tableta sadrži: 20 mg lizinopril (u obliku lizinopril, dihidrata) i 12,5 mg hidrohlorotiazid
hyperil plus 20 mg/1 tableta+ 25 mg/1 tableta tableta
zada pharmaceuticals d.o.o. - hidrohlorotiazid, lizinopril - tableta - 20 mg/1 tableta+ 25 mg/1 tableta - 1 tableta sadrži: 20 mg lizinopril (u obliku lizinopril, dihidrata) i 25 mg hidrohlorotiazid